ACR-Managed Study Suggests GLP-1 Drug May Significantly Lower Breast Cancer Risk
Newswise — Results of an American College of Radiology®-managed retrospective study involving 110,000 women presented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than …